Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 37 studies | 61% ± 29% | |
endothelial cell | 35 studies | 52% ± 22% | |
fibroblast | 32 studies | 49% ± 22% | |
smooth muscle cell | 27 studies | 69% ± 27% | |
endothelial cell of lymphatic vessel | 24 studies | 63% ± 24% | |
basal cell | 18 studies | 52% ± 20% | |
epithelial cell | 17 studies | 57% ± 24% | |
capillary endothelial cell | 13 studies | 45% ± 13% | |
endothelial cell of artery | 13 studies | 44% ± 13% | |
endothelial cell of vascular tree | 13 studies | 63% ± 25% | |
vein endothelial cell | 13 studies | 58% ± 22% | |
mesothelial cell | 11 studies | 49% ± 23% | |
type I pneumocyte | 10 studies | 66% ± 24% | |
secretory cell | 10 studies | 53% ± 15% | |
connective tissue cell | 10 studies | 43% ± 19% | |
myofibroblast cell | 10 studies | 55% ± 22% | |
enterocyte | 9 studies | 53% ± 25% | |
type II pneumocyte | 8 studies | 49% ± 11% | |
club cell | 7 studies | 47% ± 17% | |
ciliated cell | 7 studies | 30% ± 11% | |
adipocyte | 7 studies | 31% ± 7% | |
respiratory goblet cell | 6 studies | 35% ± 11% | |
kidney loop of Henle epithelial cell | 6 studies | 46% ± 14% | |
transit amplifying cell | 6 studies | 41% ± 20% | |
epithelial cell of proximal tubule | 5 studies | 45% ± 14% | |
abnormal cell | 5 studies | 47% ± 21% | |
duct epithelial cell | 4 studies | 63% ± 14% | |
squamous epithelial cell | 4 studies | 44% ± 21% | |
glomerular endothelial cell | 4 studies | 58% ± 15% | |
astrocyte | 4 studies | 49% ± 12% | |
adventitial cell | 4 studies | 49% ± 12% | |
mucus secreting cell | 4 studies | 59% ± 23% | |
luminal hormone-sensing cell of mammary gland | 4 studies | 83% ± 10% | |
luminal cell of prostate epithelium | 4 studies | 65% ± 16% | |
deuterosomal cell | 3 studies | 21% ± 1% | |
goblet cell | 3 studies | 26% ± 3% | |
intestinal crypt stem cell | 3 studies | 39% ± 11% | |
progenitor cell | 3 studies | 54% ± 6% | |
serous secreting cell | 3 studies | 51% ± 13% | |
endocardial cell | 3 studies | 32% ± 9% | |
Mueller cell | 3 studies | 54% ± 11% | |
muscle cell | 3 studies | 59% ± 22% | |
hepatocyte | 3 studies | 23% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adipose | 98% | 18.57 | 1174 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 28.02 | 1301 / 1335 | 0% | 0 | 0 / 0 |
breast | 94% | 13.43 | 431 / 459 | 0% | 0 | 0 / 1118 |
ovary | 91% | 9.31 | 164 / 180 | 0% | 0 | 0 / 430 |
uterus | 89% | 10.13 | 152 / 170 | 0% | 0 | 0 / 459 |
bladder | 86% | 7.90 | 18 / 21 | 0% | 0 | 0 / 504 |
prostate | 82% | 7.14 | 201 / 245 | 0% | 0 | 0 / 502 |
thymus | 79% | 5.99 | 516 / 653 | 0% | 0 | 0 / 605 |
lung | 60% | 4.16 | 348 / 578 | 0% | 0 | 0 / 1155 |
esophagus | 59% | 4.16 | 846 / 1445 | 0% | 0 | 0 / 183 |
kidney | 47% | 2.90 | 42 / 89 | 0% | 0 | 0 / 901 |
skin | 43% | 2.71 | 773 / 1809 | 0% | 0 | 0 / 472 |
intestine | 41% | 2.38 | 396 / 966 | 0% | 0 | 0 / 527 |
heart | 34% | 1.66 | 291 / 861 | 0% | 0 | 0 / 0 |
stomach | 34% | 1.73 | 121 / 359 | 0% | 0 | 0 / 286 |
muscle | 33% | 1.65 | 261 / 803 | 0% | 0 | 0 / 0 |
spleen | 27% | 1.24 | 66 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 14% | 0.52 | 35 / 258 | 0% | 0 | 0 / 230 |
brain | 9% | 0.37 | 240 / 2642 | 0% | 0 | 0 / 705 |
pancreas | 6% | 0.27 | 20 / 328 | 0% | 0 | 0 / 178 |
liver | 1% | 0.04 | 3 / 226 | 0% | 0 | 0 / 406 |
peripheral blood | 0% | 0.01 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030154 | Biological process | cell differentiation |
GO_0045600 | Biological process | positive regulation of fat cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | ADIRF |
Protein name | Adipogenesis regulatory factor (Adipogenesis factor rich in obesity) (Adipose most abundant gene transcript 2 protein) (Adipose-specific protein 2) (apM-2) Adipogenesis regulatory factor |
Synonyms | C10orf116 APM2 AFRO |
Description | FUNCTION: Plays a role in fat cell development; promotes adipogenic differentiation and stimulates transcription initiation of master adipogenesis factors like PPARG and CEBPA at early stages of preadipocyte differentiation. Its overexpression confers resistance to the anticancer chemotherapeutic drug cisplatin. . |
Accessions | Q15847 ENST00000561504.1 Q5TBU2 ENST00000416348.1 ENST00000372013.8 |